Updates

June 30, 2020June 30, 2020
Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

Breztri Aerosphere, AstraZeneca’s triple combination therapy for chronic obstructive pulmonary disease (COPD), significantly reduces the frequency of moderate or severe exacerbations, compared to dual ... Read more
June 25, 2020June 25, 2020
Vitamin D Deficiency Linked to Lung Function Decline, Exacerbations, Study Finds

A vitamin D deficiency in people with chronic obstructive pulmonary disease (COPD) is associated with a decline in lung function, and with increased odds ... Read more
June 23, 2020June 23, 2020
Pulmonary Rehabilitation Within 3 Months of Hospital Stay Improves Survival

Starting a pulmonary rehabilitation program within three months of hospitalization for chronic obstructive pulmonary disease, or COPD, improved the rate of survival over one ... Read more
June 18, 2020June 18, 2020
Undersized Airways May Explain Why Some Nonsmokers Develop COPD

Having small airways compared to lung size may contribute to the development of chronic obstructive pulmonary disease (COPD) in many non-smokers, a retrospective study has ... Read more
June 16, 2020June 16, 2020
Lung Denervation System Named FDA Breakthrough Device

Nuvaira‘s Lung Denervation System, under clinical investigation for its use in treating chronic obstructive pulmonary disease (COPD), has been designated a breakthrough device by ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University ... Read more

Updates

Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

Vitamin D Deficiency Linked to Lung Function Decline, Exacerbations, Study Finds

Pulmonary Rehabilitation Within 3 Months of Hospital Stay Improves Survival

Undersized Airways May Explain Why Some Nonsmokers Develop COPD

Lung Denervation System Named FDA Breakthrough Device

MUSC Resumes Clinical Trial Testing Targeted Lung Denervation

Lung Patients’ Improvement Amid UK Lockdown Spurs Call to Reduce Air Pollution

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

Overweight COPD Patients at Greater Risk of Contracting COVID-19, Study Suggests

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Subscribe to our mailing list

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

American Thoracic Society Issues New Guidelines for COPD Treatments

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

Lung Association Advises COPD Patients to Keep with Treatments in Pandemic

Ensifentrine, in Pressurized Dose Inhaler, Showing Efficacy in COPD Trial

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others

COPD Patients Vulnerable to Severe COVID-19 Infections, Study Finds

Low CC16 Protein Levels Linked to COPD Progression, Worse Lung Function in Study

Acid Reflux Linked to Higher Risk of COPD Exacerbations, Review Suggests

Disinfectant Use May Increase Nurses’ Risk of COPD, Study Finds

Coronavirus: What Every Pulmonary Patient Needs to Know!

Signant, Propeller Health to Connect Systems on Inhaler Use Data

Adding Ensifentrine to Tiotropium Therapy Improves Lung Function in COPD, Top-line Results Show

New Pulmonary Wellness Foundation Offers Free Online Rehab Programs

New Combination Respiratory Therapy for COPD Approved by FDA

Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests

New Assisted Breathing Device May Soon Be Available for Patients with Trouble Breathing

COPD Triple-combination Therapy Approved in China, AstraZeneca Announces

E-cigs Raise Risk of Chronic Lung Disease, Especially in Those Who Also Smoke, Study Finds

Propeller’s Digital Health Tool Eases Provider Burden, Boosts COPD Patient Use, Study Finds

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

Pin It on Pinterest

Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

Vitamin D Deficiency Linked to Lung Function Decline, Exacerbations, Study Finds

Pulmonary Rehabilitation Within 3 Months of Hospital Stay Improves Survival

Undersized Airways May Explain Why Some Nonsmokers Develop COPD

Lung Denervation System Named FDA Breakthrough Device

MUSC Resumes Clinical Trial Testing Targeted Lung Denervation

Lung Patients’ Improvement Amid UK Lockdown Spurs Call to Reduce Air Pollution

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

Overweight COPD Patients at Greater Risk of Contracting COVID-19, Study Suggests

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Subscribe to our mailing list

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

American Thoracic Society Issues New Guidelines for COPD Treatments

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

Lung Association Advises COPD Patients to Keep with Treatments in Pandemic

Ensifentrine, in Pressurized Dose Inhaler, Showing Efficacy in COPD Trial

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others

COPD Patients Vulnerable to Severe COVID-19 Infections, Study Finds

Low CC16 Protein Levels Linked to COPD Progression, Worse Lung Function in Study

Acid Reflux Linked to Higher Risk of COPD Exacerbations, Review Suggests

Disinfectant Use May Increase Nurses’ Risk of COPD, Study Finds

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

Coronavirus: What Every Pulmonary Patient Needs to Know!

Signant, Propeller Health to Connect Systems on Inhaler Use Data

Adding Ensifentrine to Tiotropium Therapy Improves Lung Function in COPD, Top-line Results Show

New Pulmonary Wellness Foundation Offers Free Online Rehab Programs

New Combination Respiratory Therapy for COPD Approved by FDA

Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests

New Assisted Breathing Device May Soon Be Available for Patients with Trouble Breathing

COPD Triple-combination Therapy Approved in China, AstraZeneca Announces

E-cigs Raise Risk of Chronic Lung Disease, Especially in Those Who Also Smoke, Study Finds

Propeller’s Digital Health Tool Eases Provider Burden, Boosts COPD Patient Use, Study Finds

Pin It on Pinterest